Why the study?
To emphasise the need for an interdisciplinary diagnostic approach to identify reversible causes of dilated cardiomyopathy.
Does tuberculosis treatment improve left ventricular function in a patient with dilated cardiomyopathy and concomitant pulmonary tuberculosis?
Does tuberculosis treatment improve left ventricular function in a patient with dilated cardiomyopathy and concomitant pulmonary tuberculosis?
Answers are grounded in this paper and cite their sources.
Treatment of underlying pulmonary tuberculosis can lead to partial recovery of left ventricular function in patients with dilated cardiomyopathy, highlighting the importance of identifying reversible causes.
We present the case of a young patient with dilated cardiomyopathy (DCM) and concomitant pulmonary tuberculosis (TB), emphasising the need for an interdisciplinary approach when considering underlying aetiology. A 36‐year‐old male was admitted to the hospital due to signs of acute heart failure (HF). After diagnostic work‐up, which included laboratory examination, echocardiography, and coronary angiography, a diagnosis of DCM was established and therapy was initiated. Despite optimal medical therapy for HF, the patient’s condition did not improve. During further diagnostic workup, pulmonary tuberculosis was identified. A significant reduction in HF signs and symptoms and improvement in left ventricular ejection fraction occurred only after TB was treated with 6 months of therapy. The presented case study illustrates the necessity to perform a complete diagnostic workup to identify reversible causes of DCM. JRCD 2019; 4 (2): 56-58.
No takes yet. Share an insight, caveat, or question.
Wileczek et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: